A new paper comparing axial elongation differences among untreated myopes, myopes fitted with a control contact lens and emmetropes has helped further the understanding of myopia control efficacy in the context of normal childhood eye growth. Read more
The Turkish Competition Authority has cleared EssilorLuxottica’s GrandVision takeover. It’s the final country to approve the deal, but it won’t be finalised until arbitration proceedings are ironed out between the two companies. Read more
Specsavers has reportedly entered the North American market with the acquisition of a Canadian business with 18 practices. Read more
Eyecare professionals are being urged to remain abreast of the most current myopia management methods as Australian not-for-profit the Brien Holden Vision Institute (BHVI) relaunches Myopia Awareness Week, starting Monday. Read more
New data published in the British Journal of Ophthalmology (BJO) has shown Hoya’s MiyoSmart lens continued to slow myopia progression in children after three years, while patients who switched from single vision lenses had a significant slowdown in their condition. Read more
A global data and analytics company has valued the 2020 intraocular lens (IOL) market at US$3.5 billion (AU$4.5 b), however the current resurgence in cataract procedures won’t offset COVID-19 revenue losses until 2022. Read more
RANZCO has endorsed calls for ophthalmic device manufacturers to standardise image formats, with proponents stating it is one of the most important issues preventing the profession from greater clinical and academic progress. Read more
Ophthalmologists in Florida are vehemently opposing “dangerous legislation” that would allow optometrists to perform certain types of eye surgery and prescribe medications. Read more
A new study involving Moorfields Eye Hospital has found people who consume alcohol moderately have a lower chance of developing cataracts that require surgery, especially if they consume wine. Read more
The managing director of one of Australia’s pre-eminent eye research institutions is a leading scientist behind experiments on mice that have shown promise for developing new gene therapies for both glaucoma and dementia. Read more